CyberKnife robotic image-guided stereotactic radiotherapy for oligometastic cancer: A prospective evaluation of 95 patients/118 lesions

Strahlentherapie und Onkologie

Volumn 189, Issue 6, 2013, Pages 448-455

  Jereczek Fossa, B A ^a,f   Bossi Zanetti, I ^a,f   Mauro, R ^a,f   Beltramo, G ^c   Fariselli, L ^d   Bianchi, L C ^c   Fodor, C ^a   Fossati, P ^a,b,f   Baroni, G ^b,e   Orecchia, R ^a,b,f  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b Centro Nazionale Adroterapia Oncologica CNAO   (Italy)

^c CyberKnife Center CDI   (Italy)

^d DEPARTMENT OF NEUROSURGERY   (Italy)

^e POLITECNICO DI MILANO   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

Computed tomography; Metastasis; Positron emission tomography; Survival; Toxicity

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CAUSE SPECIFIC SURVIVAL; CLINICAL TRIAL; CYBERKNIFE; DIGESTIVE SYSTEM CANCER; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; IMAGE GUIDED RADIOTHERAPY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; OLIGOMETASTASIS; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; ROBOTICS; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACTUARIAL ANALYSIS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; COMPUTER SIMULATION; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; PROSPECTIVE STUDIES; RADIOSURGERY; ROBOTICS; SURGERY, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84878325562     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0345-y     Document Type: Article

References (29)

1. Benedict SH, Lin PS, Zwicker RD, et al. (1997) The biological effectiveness of intermittent irradiation as a function of overall treatment time: development of correction factors for linac based stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 37:765-769 (Pubitemid 27181306)
2. Cheng YC, Ueno NT (2012) Improvement of survival and prospect of cure in patients with metastatic breast cancer. Breast Cancer 19:191-199
3. Chua TC, Liauw W, Chu F, Morris DL (2012) Viewing metastatic colorectal cancer as curable chronic disease. Am J Clin Oncol 35:77-80
4. Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341-1346
5. D'Agostino GR, Autorino R, Pompucci A, et al. (2011) Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis. Strahlenther Onkol 187:421-425
6. Dahele M, Senan S (2011) The role of stereotactic ablative radiotherapy for early-stage and oligometastatic non-small cell lung cancer: evidence for changing paradigms. Cancer Res Treat 43:75-82
7. Eisenhauer EA, Therasse P, Bogaerts J, et al. (2009) New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 45:228-247
8. Fokas E, Henzel M, Engenhart-Cabillic R (2010) A comparison of radiotherapy with radiotherapy plus surgery for brain metastases from urinary bladder cancer: analysis of 62 patients. Strahlenther Onkol 186:565-571 (Erratum in: Strahlenther Onkol 2011;187:267)
9. Fowler JF, Welsh JS, Howard SP (2004) Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol Biol Phys 159:242-249 (Pubitemid 38501529)
10. Geiger S, Cnossen JA, Horster S, et al. (2011) Long-term follow-up of patients with metastatic breast cancer: results of a retrospective, single-center analysis from 2000-2005. Anticancer Drugs 22:933-939
11. Gill B, Oermann E, Ju A, et al. (2012) Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach. Front Oncol 2:39
12. Halley ML, Gerszten PC, Heron DE, et al. (2011) Efficacy and cost-effectiveness analysis of external beam and stereotactic body radiation therapy in the treatment of spine metastases: a matched-pair analysis. J Neurosurg Spine 14:537-542
13. Jabbour SK, Daroui P, Moore D, et al. (2011) A novel paradigm in the treatment of oligometastatic non-small cell lung cancer. J Thorac Dis 3:4-9
14. Jereczek-Fossa BA, Beltramo G, Fariselli L, et al. (2012) Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastastic prostate cancer. Int J Radiat Oncol Biol Phys 82:889-897
15. Kaplan E, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
16. Lee MK, Baek SK, Kim SY, et al. (2011) Awareness of incurable cancer status and health-related quality of life among advanced cancer patients: a prospective cohort study. Palliat Med (Epub ahead of print)
17. Milano MT, Katz AW, Zhang H, Okunieff P (2012) Oligometastases treated with stereotactic body radiotherapy: long term follow-up of prospective study. Int J Radiat Oncol Biol Phys 83:878-886
18. Riboldi M, Orecchia R, Baroni G (2012) Real-time tumour tracking in particle therapy: technological developments and future perspectives. Lancet Oncol 13:e383-e391
19. Ricardi U, Filippi AR, Guarneri A, et al. (2012) Stereotactic body radiation therapy for lung metastases. Lung Cancer 75:77-81
20. Salama JK, Hasselle MD, Chmura SJ, et al. (2012) Stereotactic body radiotherapy for multisite extracranial metastases. Cancer 118:2962-2970
21. Thariat J, Li G, Angellier G, et al. (2009) Current indications and ongoing clinical trials with CyberKnife stereotactic radiotherapy in France in 2009. Bull Cancer 96:853-864 (article in French)
22. Torshabi AE, Pella A, Riboldi M, Baroni G (2010) Targeting accuracy in real-time tumor tracking via external surrogates: a comparative study. Technol Cancer Res Treat 9:551-562
23. Vavassori A, Jereczek-Fossa BA, Beltramo G, et al. (2010) Image-guided robotic radiosurgery as salvage therapy for locally recurrent prostate cancer after external beam irradiation: retrospective feasibility study on six cases. Tumori 96:71-75
24. Voigtmann K, Köllner V, Einsle F, et al. (2010) Emotional state of patients in radiotherapy and how they deal with their disorder. Strahlenther Onkol 186:229-235
25. Wiechselbaum RR, Hellman S (2011) Oligometastases revisited. Nat Rev Clin Oncol 8:378-382
26. Wiggenraad R, Verbeek-de Kanter A, Mast M, et al. (2012) Local progression and pseudo progression after single fraction or fractionated stereotactic radiotherapy for large brain metastases: a single centre study. Strahlenther Onkol 188:696-701
27. Wilhelm M (2012) Impaired cognitive function and structural changes in cerebral white matter after chemotherapy. Strahlenther Onkol 188:525-526 (article in German)
28. Xie Y, Djajaputra D, King CR, et al. (2008) Intrafractional motion of the prostate during hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys 72:236-246
29. Zabel-du Bois A, Milker-Zabel S, Henzel M, et al. (2012) Evaluation of time, attendance of medical staff, and resources during stereotactic radiotherapy/radiosurgery: QUIRO-DEGRO Trial. Strahlenther Onkol (Epub ahead of print)